Adverum Biotechnologies (ADVM) Stock Analysis

What Adverum Biotechnologies does

Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various eye-related conditions and uncommon illnesses. Its flagship experimental gene therapy, ADVM-022, is a potential therapy administered through a single injection into the vitreous humor of the eye. This treatment is being developed for individuals afflicted with persistent retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies maintains licensing and collaborative partnerships with institutions such as the University of California and Cornell University, as well as companies like GenSight, Lexeo, and Virovek. Established in 2006, the organization was initially named Avalanche Biotechnologies, Inc. before rebranding to Adverum Biotechnologies, Inc. in May 2016. Its headquarters are situated in Redwood City, California.

Key metrics

ETFs linked to ADVM

Broad-market and Healthcare sector ETFs an investor holding Adverum Biotechnologies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ADVM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Adverum Biotechnologies?

Adverum Biotechnologies trades under the ticker ADVM on NASDAQ.

Which exchange is ADVM listed on?

ADVM is listed on NASDAQ.

What sector does Adverum Biotechnologies operate in?

Adverum Biotechnologies is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ADVM in a portfolio?

PortView shows ADVM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.